National Academies Press: OpenBook
« Previous: Appendix B: Workshop Statement of Task
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×

Appendix C

Workshop Agenda

WORKSHOP PART 1
THURSDAY, JULY 22, 2021
11:00 AM–1:00 PM ET

11:00 AM Welcome Remarks, Workshop Overview, and Goals
Kenneth Castro, workshop co-chair
Gail Cassell, workshop co-chair
11:05 AM Opening Addresses: Current Status and Urgency of Ending TB Around the Globe
Jim Yong Kim (Global Infrastructure Partners)
Salmaan Keshavjee (Harvard Medical School)
Eric Rubin (New England Journal of Medicine)
Moderator: Lucica Ditiu
11:30 AM Diagnostics
Soumya Swaminathan (World Health Organization)
11:40 AM Vaccines and Therapeutics
Emilio Emini (Bill & Melinda Gates Foundation)
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
11:50 AM Critical Need for New Business Models
Kevin Outterson (Boston University School of Law)
12:00 PM Discussion (50 min)
12:55 PM Wrap-up and Adjourn
Gail Cassell, workshop co-chair
Kenneth Castro, workshop co-chair

WORKSHOP—PART TWO
TUESDAY, SEPTEMBER 14, 2021
11:00 AM–2:30 PM ET

11:00 AM Welcome and Workshop Goals
Peter Daszak, Chair, Forum on Microbial Threats, National Academy of Medicine; President, EcoHealth Alliance
Lucica Ditiu, moderator, Stop TB Partnership
11:05 AM Sponsor Remarks
Jennifer Adams, Senior Deputy Assistant Administrator, Bureau for Global Health, United States Agency for International Development
11:20 AM Building a Tuberculosis-Free World: Progress Update
Eric Goosby (University of California, San Francisco)
15 min Q&A
Realities of Multidrug-Resistant TB and Challenges for TB Control
Matteo Zignol (World Health Organization)
15 min Q&A
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
12:15 PM Rapid Acceleration of Diagnostics: The COVID-19 Experience
Matthew McMahon (Director, Small Business Education and Entrepreneurial Development, NIH)
15 min Q&A
12:45 PM Panel Discussion on Diagnostic Advances
Point-of-Care Molecular Platform for Diagnosis of TB and Other Infectious Respiratory Diseases
Morten Ruhwald (FIND, the global alliance for diagnostics)
Platform Technologies for Detection of Multiple Agents
Zvi Marom (BATM) and Eran Zahavy (BATM)
Improving X-Ray Accessibility
Luan Vo (Friends for International Tuberculosis Relief)
Implementation Challenges with New TB Diagnostics
Kaiser Shen (USAID)
1:15 PM Enhancing Adherence, Infection Control Capacities, and Cost-Effectiveness
Expansion and Improvements to Contact Tracing and Engagement: Mobile or Digital Platforms from the COVID-19 Pandemic
Aamir Khan (IRD)
Telehealth and Digital Adherence Technologies
Bruce Thomas (The Arcady Group)
Innovative Strategies to Share the Costs of Investments in Health Care Systems by Partnering with Other Disease Burdens in LMICs
Monique K. Mansoura (MITRE)
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
Infection Prevention
Edward Nardell (Harvard Medical School, Brigham and Women’s Hospital)
Management of Latent TB Infection: Gaps and Opportunities
Gavin Churchyard (The Aurum Institute)
2:15 PM Reflections on Session 1
Lucica Ditiu
2:30 PM Adjourn

WORKSHOP PART 2
WEDNESDAY, SEPTEMBER 15, 2021
11:00 AM–2:30 PM ET

11:00 AM Welcome and Session Goals
Kent Kester, moderator, Sanofi Pasteur
11:05 AM Using Existing Tools and New Technologies
BCG Revaccination
Alex Schmidt (Bill & Melinda Gates Medical Research Institute)
Promising New Adjuvants and Late-Stage Clinical Development Vaccine Candidates
Steve Reed (University of Washington; HDT Bio)
How Host-Directed Therapies Can Change the Development Landscape
Daniel Kalman (Emory University)
Immune Mechanisms of Protection Against TB
Rhea Coler (Seattle Children’s Hospital)
12:00 PM Transforming Treatment Options
Charles Wells, moderator, Bill & Melinda Gates Medical Research Institute
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
The Key to Success for Developing a New Regimen to Advance TB Treatment: Lessons from TBTC Study 31 (S31/A5349)
Payam Nahid (University of California, San Francisco)
What It Takes to Roll Out a New Treatment Regimen: Lessons from Drug-Resistant TB
Adrian Thomas (Johnson & Johnson)
Norbert Ndjeka (National Department of Health, Republic of South Africa)
Bringing Innovation to the Development of New Transformative TB Regimens
David Hermann (Bill & Melinda Gates Foundation)
Importance of Context-Specific Economic Analyses to Inform Future Program Design and Investment
Anna Vassall (London School of Hygiene & Tropical Medicine)
1:00 PM Expert Reflections and Discussion on Critical Elements for Implementation
Ezra Shimeles Tessera (TB Data, Impact Assessment and Communications Hub, USAID; John Snow, Inc.)
Richard Chaisson (Johns Hopkins University School of Medicine and Bloomberg School of Public Health)
2:15 PM Reflections on Session 2
Kent Kester
Charles Wells
2:30 PM Adjourn

WORKSHOP PART 2
THURSDAY, SEPTEMBER 16, 2021
11:00 AM–2:30 PM ET

11:00 AM Welcome: Session Goals and Bold Moves
Peter Sands, moderator, The Global Fund
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
11:10 AM Opening Remarks
Victor Dzau, President, National Academy of Medicine
11:15 AM A Place for TB in the Pandemic Preparedness Agenda
Tharman Shanmugaratnam, Senior Minister, Singapore, and co-chair, G20 High-Level Independent Panel on Financing the Global Commons for Pandemic Preparedness and Response
11:50 AM Achieving Synergy in Global Health Security Preparedness Against Respiratory Pathogens: Recognition of TB as a Leading Killer
Peter Sands, moderator
John Bell (University of Oxford)
Bruce Gellin (The Rockefeller Foundation)
Rebecca Katz (Georgetown University, Center for Global Health Science and Security)
Michael Callahan (Massachusetts General Hospital; United Therapeutics)
1:05 PM Making the Case for Financing TB Elimination
Margaret Hamburg, moderator, Nuclear Threats Initiative
The Cost of Failing to Achieve the End TB Targets: A Full Economic Analysis
Michael Reid (University of California, San Francisco)
Why TB Is One of the Best Investments on the SDG Agenda
Bjorn Lomborg (Copenhagen Consensus Center)
Smart Investments in Ending TB
Mark Dybul (Georgetown University; Enochian BioSciences)
Implications for TB from the High-Level Independent Panel on Financing the Global Commons for Pandemic Preparedness and Response
Amanda Glassman (Center for Global Development)
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
2:00 PM Closing Remarks
Margaret Hamburg
Gail Cassell, workshop co-chair
Kenneth Castro, workshop co-chair
2:30 PM Adjourn
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×

This page intentionally left blank.

Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
Page 167
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
Page 168
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
Page 169
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
Page 170
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
Page 171
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
Page 172
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
Page 173
Suggested Citation:"Appendix C: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26530.
×
Page 174
Innovations for Tackling Tuberculosis in the Time of COVID-19: Proceedings of a Workshop Get This Book
×
Buy Paperback | $30.00 Buy Ebook | $24.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Despite being preventable and curable since the middle of the twentieth century, tuberculosis (TB) has long persisted as the world's deadliest infectious disease, with the communities most devastated by TB among the poorest and most vulnerable in the world. Only about half of people with TB receive successful treatment each year. As the global threat of antimicrobial resistance continues to escalate, so do cases of drug-resistant TB, or TB that is resistant to various antibiotics that constitute standard treatment regimens.

In response, the National Academies of Sciences, Engineering, and Medicine's Forum on Microbial Threats held a two-part virtual workshop on July 22 and September 14-16, 2021 titled Innovations for Tackling Tuberculosis in the Time of COVID-19. The aims of the workshop were to evaluate the current status of TB elimination, assess the effects of the COVID-19 pandemic on the global fight against TB, and examine technical and strategic innovations that could be leveraged to meet the United Nations High-Level Meeting on Tuberculosis targets in 2022 and The World Health Organization's END TB Strategy targets by 2030. This publication summarizes the presentations and discussions of the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!